+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Consumer News Pfizer Says Its Covid 19 Vaccine Could Be Ready By Late November is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Consumer News Pfizer Says Its Covid 19 Vaccine Could Be Ready By Late November | RobinsPost News & Noticias

A one-shot vaccine for COVID, flu and future viruses? Researchers say it's coming


But what if it were possible to protect against COVID and the flu, and other unknown viruses that haven't yet emerged, with just one shot? If that became reality, seasonal or annual boosters would be ... Read More

Ken Paxton sues Pfizer over alleged misrepresentation of COVID-19 vaccine efficacy


"Since its initial authorization by FDA in December 2020, the Pfizer-BioNTech COVID-19 vaccine has been administered to more than 1.5 billion people, demonstrated a favorable safety profile in all ... Read More

Vaccines News


Optimizing Boosters: How COVID mRNA Vaccines Reshape Immune Memory After Each Dose Mar. 8, 2024 — COVID-19 vaccines elicit ... 2024 — Could the TB vaccine be a new immunotherapy for liver ... Read More

Texas lawsuit claims Pfizer exaggerated effectiveness of COVID-19 vaccine


“The representations made by the company about its COVID-19 vaccine have been accurate and science-based,” it read. The lawsuit is Paxton’s second against Pfizer in November. The attorney ... Read More

Moderna says its next-gen Covid-19 is better than current version


Moderna Inc. says the newest version of its Covid-19 vaccine could have a longer shelf life ... Edition or Afternoon Edition for the business news you need to know, all free. Read More

Pfizer to seek approval for RSV vaccine for people as young as 18


(CNN) — An RSV vaccine already used for older adults could help protect people as young as 18 who are at increased risk of the disease, drugmaker Pfizer said in a news release Tuesday. Read More

Is Pfizer Stock a Buy?


Pfizer (NYSE: PFE) isn't exactly a hot stock right now. Since its massive run-up during the pandemic's height, built on hopes for its coronavirus vaccine, new sources of growth haven't led to ... Read More

COVID and SARS News


A Universal Coronavirus Vaccine Could Save Billions of Dollars If Ready Before Next Pandemic ... Lower in Severity Than Delta, and Pfizer-BioNTech COVID Vaccine Remains Effective in Preventing ... Read More

Pfizer wins pause on Moderna's COVID-19 patent lawsuit


opens new tab copied its COVID-19 vaccine ... Pfizer's request, arguing a stay would be "highly prejudicial" and unnecessarily delay an infringement trial that Stearns has said could be held ... Read More

Khairy: We’ll get a million Pfizer-BioNTech vaccines


PETALING JAYA: The country will receive one million doses of the Pfizer-BioNTech Covid-19 vaccine in its first phase to inoculate Malaysians, says Science, Technology and Innovation Minister ... Read More

People in Bolton told its not too late for Covid-19 vaccines


People all over Bolton who are eligible have been told “it’s not too late” to get their Covid ... vaccination by going to the Getting a Covid-19 vaccine section on the NHS’s website. Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus